Literature DB >> 1517750

Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis.

J Y Salle1, J Hugon, F Tabaraud, J M Boulesteix, J M Vallat, M Dumas, C M Poser.   

Abstract

Motor evoked potentials (MEP) were recorded in 23 patients with definite relapsing multiple sclerosis before and after treatment with a short course of high dose of methylprednisolone. MEP were performed together with clinical examination just before treatment, and 6 and 60 days later. The following results were observed: (1) a statistically significant relationship between the corticospinal deficit and the alteration in MEP, (2) a significant improvement in latency of MEP by day 6, (3) a significant correlation between the change in the Kurtzke disability scale rating and the improvement in MEP. The results provide further evidence for the possible effectiveness of short courses of high dose corticosteroids in the treatment of relapses of multiple sclerosis and the usefulness of MEP in its assessment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517750     DOI: 10.1016/0022-510x(92)90049-q

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.

Authors:  A M Humm; W J Z'Graggen; R Bühler; M R Magistris; K M Rösler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-20       Impact factor: 10.154

2.  Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities.

Authors:  Andrea Gagliardo; Francesca Galli; Antonello Grippo; Aldo Amantini; Cristiana Martinelli; Maria Pia Amato; Walter Borsini
Journal:  J Neurol       Date:  2007-02-17       Impact factor: 4.849

3.  Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment.

Authors:  L La Mantia; F Riti; C Milanese; A Salmaggi; M Eoli; C Ciano; G Avanzini
Journal:  Ital J Neurol Sci       Date:  1994-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.